Biomarkers in Inflammatory Myopathies – An Expanded Definition

Biomarkers as parameters of pathophysiological conditions can be of outmost relevance for inflammatory myopathies. They are particularly warranted to inform about diagnostic, prognostic, and therapeutic questions. As biomarkers become more and more relevant in daily routine, this review focusses on relevant aspects particularly addressing myopathological features. However, the level of evidence to use them in daily routine at presence is low, still since none of them has been validated in large cohorts of patients and rarely in independent biopsy series. Hence, they should be read as mere expert opinions. The evaluation of biomarkers as well as key biological parameters is an ongoing process, and we start learning about relevance of them, as we must recognize that pathophysiology of myositis is biologically incompletely understood. As such this approach should be considered an essay toward expansion of the definition “biomarker” to myositis, an emerging field of interest in biomedical research

Freshwater Requirements of Large-Scale Bioenergy Plantations for Limiting Global Warming to 1.5C

Limiting mean global warming to well below 2 C will probably require substantial negative emissions (NEs) within the 21st century. To achieve these, bioenergy plantations with subsequent carbon capture and storage (BECCS) may have to be implemented at a large scale. Irrigation of these plantations might be necessary to increase the yield, which is likely to put further pressure on already stressed freshwater systems. Conversely, the potential of bioenergy plantations (BPs) dedicated to achieving NEs through CO2 assimilation may be limited in regions with low freshwater availability. This paper provides a first-order quantification of the biophysical potentials of BECCS as a negative emission technology contribution to reaching the 1.5 C warming target, as constrained by associated water availabilities and requirements. Using a global biosphere model, we analyze the availability of freshwater for irrigation of BPs designed to meet the projected NEs to fulfill the 1.5 C target, spatially explicitly on areas not reserved for ecosystem conservation or agriculture. We take account of the simultaneous water demands for agriculture, industries, and households and also account for environmental flow requirements (EFRs) needed to safeguard aquatic ecosystems. Furthermore, we assess to what extent different forms of improved water management on the suggested BPs and on cropland may help to reduce the freshwater abstractions. Results indicate that global water withdrawals for irrigation of BPs range between ~400 and ~3000 km(exp 3) yr(exp -1), depending on the scenario and the conversion efficiency of the carbon capture and storage process. Consideration of EFRs reduces the NE potential significantly, but can partly be compensated for by improved on-field water management

Identification of the Endogenous Key Substrates of the Human Organic Cation Transporter OCT2 and Their Implication in Function of Dopaminergic Neurons

BACKGROUND: The etiology of neurodegenerative disorders, such as the accelerated loss of dopaminergic neurons in Parkinson's disease, is unclear. Current hypotheses suggest an abnormal function of the neuronal sodium-dependent dopamine transporter DAT to contribute to cell death in the dopaminergic system, but it has not been investigated whether sodium-independent amine transporters are implicated in the pathogenesis of Parkinson's disease. METHODOLOGY/PRINCIPAL FINDINGS: By the use of a novel tandem-mass spectrometry-based substrate search technique, we have shown that the dopaminergic neuromodulators histidyl-proline diketopiperazine (cyclo(his-pro)) and salsolinol were the endogenous key substrates of the sodium-independent organic cation transporter OCT2. Quantitative real-time mRNA expression analysis revealed that OCT2 in contrast to its related transporters was preferentially expressed in the dopaminergic regions of the substantia nigra where it colocalized with DAT and tyrosine hydroxylase. By assessing cell viability with the MTT reduction assay, we found that salsolinol exhibited a selective toxicity toward OCT2-expressing cells that was prevented by cyclo(his-pro). A frequent genetic variant of OCT2 with the amino acid substitution R400C reduced the transport efficiency for the cytoprotective cyclo(his-pro) and thereby increased the susceptibility to salsolinol-induced cell death. CONCLUSIONS/SIGNIFICANCE: Our findings indicate that the OCT2-regulated interplay between cyclo(his-pro) and salsolinol is crucial for nigral cell integrity and that a shift in transport efficiency may impact the risk of Parkinson's disease

Freshwater requirements of large-scale bioenergy plantations for limiting global warming to 1.5 °C

Limiting mean global warming to well below 2 °C will probably require substantial negative emissions (NEs) within the 21st century. To achieve these, bioenergy plantations with subsequent carbon capture and storage (BECCS) may have to be implemented at a large scale. Irrigation of these plantations might be necessary to increase the yield, which is likely to put further pressure on already stressed freshwater systems. Conversely, the potential of bioenergy plantations (BPs) dedicated to achieving NEs through CO2 assimilation may be limited in regions with low freshwater availability. This paper provides a first-order quantification of the biophysical potentials of BECCS as a negative emission technology contribution to reaching the 1.5 °C warming target, as constrained by associated water availabilities and requirements. Using a global biosphere model, we analyze the availability of freshwater for irrigation of BPs designed to meet the projected NEs to fulfill the 1.5 °C target, spatially explicitly on areas not reserved for ecosystem conservation or agriculture. We take account of the simultaneous water demands for agriculture, industries, and households and also account for environmental flow requirements (EFRs) needed to safeguard aquatic ecosystems. Furthermore, we assess to what extent different forms of improved water management on the suggested BPs and on cropland may help to reduce the freshwater abstractions. Results indicate that global water withdrawals for irrigation of BPs range between ∼400 and ∼3000 km3 yr−1, depending on the scenario and the conversion efficiency of the carbon capture and storage process. Consideration of EFRs reduces the NE potential significantly, but can partly be compensated for by improved on-field water management

Freshwater requirements of large-scale bioenergy plantations for limiting global warming to 1.5 °C

Limiting mean global warming to well below 2 °C will probably require substantial negative emissions (NEs) within the 21st century. To achieve these, bioenergy plantations with subsequent carbon capture and storage (BECCS) may have to be implemented at a large scale. Irrigation of these plantations might be necessary to increase the yield, which is likely to put further pressure on already stressed freshwater systems. Conversely, the potential of bioenergy plantations (BPs) dedicated to achieving NEs through CO2 assimilation may be limited in regions with low freshwater availability. This paper provides a first-order quantification of the biophysical potentials of BECCS as a negative emission technology contribution to reaching the 1.5 °C warming target, as constrained by associated water availabilities and requirements. Using a global biosphere model, we analyze the availability of freshwater for irrigation of BPs designed to meet the projected NEs to fulfill the 1.5 °C target, spatially explicitly on areas not reserved for ecosystem conservation or agriculture. We take account of the simultaneous water demands for agriculture, industries, and households and also account for environmental flow requirements (EFRs) needed to safeguard aquatic ecosystems. Furthermore, we assess to what extent different forms of improved water management on the suggested BPs and on cropland may help to reduce the freshwater abstractions. Results indicate that global water withdrawals for irrigation of BPs range between ∼400 and ∼3000 km3 yr−1, depending on the scenario and the conversion efficiency of the carbon capture and storage process. Consideration of EFRs reduces the NE potential significantly, but can partly be compensated for by improved on-field water management.University of Chicago Center for Robust Decision-making on Climate and Energy PolicyBMBF project BioCAP-CCSDeutsche Forschungsgemeinschaft SPP 1689 on ‘Climate Engineering: Risks, Challenges, Opportunities?’Peer Reviewe

Inclusion body myositis and associated diseases: an argument for shared immune pathologies

Inclusion body myositis (IBM) is the most prevalent idiopathic inflammatory myopathy (IIM) affecting older adults. The pathogenic hallmark of IBM is chronic inflammation of skeletal muscle. At present, we do not classify IBM into different sub-entities, with the exception perhaps being the presence or absence of the anti-cN-1A-antibody. In contrast to other IIM, IBM is characterized by a chronic and progressive disease course. Here, we discuss the pathophysiological framework of IBM and highlight the seemingly prototypical situations where IBM occurs in the context of other diseases. In this context, understanding common immune pathways might provide insight into the pathogenesis of IBM. Indeed, IBM is associated with a distinct set of conditions, such as human immunodeficiency virus (HIV) or hepatitis C-two conditions associated with premature immune cell exhaustion. Further, the pathomorphology of IBM is reminiscent of other muscle diseases, notably HIV-associated myositis or granulomatous myositis. Distinct immune pathways are likely to drive these commonalities and senescence of the CD8(+) T cell compartment is discussed as a possible mechanism of pathogenesis. Future effort directed at understanding the co-occurrence of IBM and associated diseases could prove valuable to better understand the enigmatic IBM pathophysiology

Proteomic Profiling Unravels a Key Role of Specific Macrophage Subtypes in Sporadic Inclusion Body Myositis

Unbiased proteomic profiling was performed toward the identification of biological parameters relevant in sIBM, thus giving hints about the pathophysiological processes and the existence of new reliable markers. For that purpose, skeletal muscle biopsies from 13 sIBM and 7 non-diseased control patients were analyzed with various methods, including liquid chromatography coupled to tandem mass spectrometry (four patients). Subsequent data analysis identified key molecules further studied in a larger cohort by qPCR, immunostaining, and immunofluorescence in situ. Proteomic signature of muscle biopsies derived from sIBM patients revealed the chaperone and cell surface marker CD74, the macrophage scavenger molecule CD163 and the transcription activator STAT1 to be among the highly and relevantly expressed proteins suggesting a significant contribution of immune cells among the myofibers expressing these markers. Moreover, in silico studies showed that 39% of upregulated proteins were involved in type I or mixed type I and type II interferon immunity. Indeed, further studies via immunohistochemistry clearly confirmed the prominent involvement of the key type I interferon signature-related molecules, ISG15 as well as IRF8 with MHC class II+ myofibers. Siglec1 colocalized with CD163+ macrophages and MHC class II molecules also co-localized with CD74 on macrophages. STAT1 co-localized with Siglec1+ macrophages in activemyofibremyophagocytosis while STAT6 colocalized with endomysial macrophages. These combined results show involvement of CD74, CD163, and STAT1 as key molecules of macrophage activation being crucially involved in mixed and specific type I interferon, and interferon gamma associated-pathways in sIBM. On a more general note, these results also highlight the type of immune-interaction between macrophages and myofibers in the etiopathology of sIBM

Proteomic Profiling Unravels a Key Role of Specific Macrophage Subtypes in Sporadic Inclusion Body Myositis

Unbiased proteomic profiling was performed toward the identification of biological parameters relevant in sIBM, thus giving hints about the pathophysiological processes and the existence of new reliable markers. For that purpose, skeletal muscle biopsies from 13 sIBM and 7 non-diseased control patients were analyzed with various methods, including liquid chromatography coupled to tandem mass spectrometry (four patients). Subsequent data analysis identified key molecules further studied in a larger cohort by qPCR, immunostaining, and immunofluorescence in situ. Proteomic signature of muscle biopsies derived from sIBM patients revealed the chaperone and cell surface marker CD74, the macrophage scavenger molecule CD163 and the transcription activator STAT1 to be among the highly and relevantly expressed proteins suggesting a significant contribution of immune cells among the myofibers expressing these markers. Moreover, in silico studies showed that 39% of upregulated proteins were involved in type I or mixed type I and type II interferon immunity. Indeed, further studies via immunohistochemistry clearly confirmed the prominent involvement of the key type I interferon signature-related molecules, ISG15 as well as IRF8 with MHC class II+ myofibers. Siglec1 colocalized with CD163+ macrophages and MHC class II molecules also co-localized with CD74 on macrophages. STAT1 co-localized with Siglec1+ macrophages in active myofibre myophagocytosis while STAT6 colocalized with endomysial macrophages. These combined results show involvement of CD74, CD163, and STAT1 as key molecules of macrophage activation being crucially involved in mixed and specific type I interferon, and interferon gamma associated-pathways in sIBM. On a more general note, these results also highlight the type of immune-interaction between macrophages and myofibers in the etiopathology of sIBM

Novel bi-allelic variants expand the SPTBN4-related genetic and phenotypic spectrum

Neurodevelopmental disorder with hypotonia, neuropathy, and deafness (NEDHND, OMIM #617519) is an autosomal recessive disease caused by homozygous or compound heterozygous variants in SPTBN4 coding for type 4 beta IV-spectrin, a non-erythrocytic member of the beta-spectrin family. Variants in SPTBN4 disrupt the cytoskeletal machinery that controls proper localization of ion channels and the function of axonal domains, thereby generating severe neurological dysfunction. We set out to analyze the genetic causes and describe the clinical spectrum of suspected cases of NEDHND. Variant screening was done by whole exome sequencing; clinical phenotypes were described according to the human phenotype ontology, and histochemical analysis was performed with disease-specific antibodies. We report four families with five patients harboring novel homozygous and compound heterozygous SPTBN4 variants, amongst them a multi-exon deletion of SPTBN4. All patients presented with the key features of NEDHND; severe muscular hypotonia, dysphagia, absent speech, gross motor, and mental retardation. Additional symptoms comprised horizontal nystagmus, epileptiform discharges in EEG without manifest seizures, and choreoathetosis. Muscle histology revealed both characteristics of myopathy and of neuropathy. This report expands the SPTBN4 variant spectrum, highlights the spectrum of morphological phenotypes of NEDHND-patients, and reveals clinical similarities between the NEDHND, non-5q SMA, and congenital myopathies